SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences - Quaterly Results

28 Apr 2025 Evaluate
The company witnessed a 12.68% growth in the revenue at Rs. 1430.90 millions for the quarter ended March 2025 as compared to Rs. 1269.90 millions during the year-ago period.The Net Profit of the company vaulted to 786.33% to Rs. 1173.50  millions from Rs. 132.40 millions in the previous quarter.Operating profit for the quarter ended March 2025 rose to 305.50 millions as compared to 223.70 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1430.90 1269.90 12.68 6534.30 5820.50 12.26 6534.30 5820.50 12.26
Other Income 50.60 16.50 206.67 126.80 72.10 75.87 126.80 72.10 75.87
PBIDT 305.50 223.70 36.57 1723.30 1353.60 27.31 1723.30 1353.60 27.31
Interest 1.80 1.40 28.57 6.20 4.50 37.78 6.20 4.50 37.78
PBDT 1402.70 222.30 530.99 2543.10 1349.10 88.50 2543.10 1349.10 88.50
Depreciation 53.70 44.90 19.60 214.30 170.70 25.54 214.30 170.70 25.54
PBT 1349.00 177.40 660.43 2328.80 1178.40 97.62 2328.80 1178.40 97.62
TAX 175.50 45.00 290.00 496.40 301.80 64.48 496.40 301.80 64.48
Deferred Tax 0.70 -9.50 -107.37 -0.50 -23.60 -97.88 -0.50 -23.60 -97.88
PAT 1173.50 132.40 786.33 1832.40 876.60 109.03 1832.40 876.60 109.03
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 21.35 17.62 21.20 26.37 23.26 13.40 26.37 23.26 13.40

RPG Life Sciences Share Price

1893.15 14.10 (0.75%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×